As the month of October begins and broader markets sold off, biotech stocks are still largely negative and/ or flat for the year. As seen in the LABU vs. LABD chart below, the spread between the two … [Read more...] about Biotech: Time To Buy the Bull
biotech catalysts
An Intriguing Play In Immune-Oncology For Summer 2019
Happy Friday everyone! The end of the Q2 is nearly upon us (June 30th). Going into the 2nd half of the year I want to present for our members up and coming companies on the path to success. In my last … [Read more...] about An Intriguing Play In Immune-Oncology For Summer 2019
A Look At ADMA Biologics Investor Presentation At Jefferies 2019 Healthcare Conference
ADMA Biologics (Nasdaq: ADMA), an innovator in the manufacturing and sale of intravenous immunoglobulin (IVIG) medicine, delivered a 23 minute presentation June 6th at the Jefferies 2019 Healthcare … [Read more...] about A Look At ADMA Biologics Investor Presentation At Jefferies 2019 Healthcare Conference
Biopharma Stock Watch May 13th-17th
The trade talks between the U.S. and Chinese officials have come and gone leaving no trade deal in place. While U.S markets were not rocked as hard as Asia's it was a still a relatively bloody week. … [Read more...] about Biopharma Stock Watch May 13th-17th
You must be logged in to post a comment.